Literature DB >> 35317086

Iatrogenic Infective Endocarditis With Septic Emboli: An Unusual Complication of Intracardiac Manipulation.

Ndausung Udongwo1, Nusha Fareen1, Temidayo Abe2, Mihir Odak1, SmArif Saleh1, Laith Zamel3.   

Abstract

Radiofrequency catheter ablation (RFA) is an effective treatment for recurrent symptomatic atrial fibrillation (AF) despite medical therapy. Complications include cardiac tamponade, pulmonary vein stenosis, and rarely atrial-esophageal fistula (AEF). We present a case of a 77-year-old male patient with a history of persistent AF status post posterior left atrial isolation 50 days prior, who presented to the emergency department with bilateral lower extremity weakness ongoing for an hour. In addition, he reported a non-productive cough, chest discomfort, and dysphagia. He was hypertensive, febrile, tachycardic, and with tachypnea on initial assessment. Initial labs revealed leukocytosis with elevated troponin level. Brain imaging confirmed subacute infarcts suggestive of embolic disease. Tissue plasminogen activator was contraindicated. He was admitted for management of altered mental status and sepsis of an unknown origin. Due to associated chest discomfort and dysphagia, computed tomography (CT) scan of the chest with contrast obtained revealed a small focus of air between the posterior wall of the left atrium and the esophagus. A few hours later, he deteriorated with worsened hypoxic respiratory failure, altered mental status, requiring intubation and mechanical ventilation. Cardiothoracic surgery was consulted, and he was taken to the operating room for open-heart surgery due to concern for AEF. Peri-operatively, a left atrial fistula measuring 0.5 cm was identified and closed. Also, a fibrinous material (3 × 4 cm) was identified and removed in the left inferior pulmonary vein. On post-operative day 1, he underwent an upper endoscopy, and a 1 cm esophageal defect was closed. Biopsy from fibrinous material was positive for polymicrobial organisms (lactobacillus, candida, and prevotella), while blood cultures grew Streptococcus anginosus. Despite treatment with aggressive intravenous antibiotics, the patient deteriorated with poor neurological function and ventilator dependency. A multidisciplinary team reached a consensus agreement for palliative measures. To our knowledge, this case represents one of the few cases documenting life-threatening infective endocarditis with septic emboli as a complication of AEF from RFA. Therefore, clinicians should have a high index of suspicion due to associated grave prognosis. Copyright 2022, Udongwo et al.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Atrial-esophageal fistula; Embolic stroke; Fistula; Iatrogenic; Pulmonary vein isolation; Thromboembolism

Year:  2022        PMID: 35317086      PMCID: PMC8913009          DOI: 10.14740/jmc3879

Source DB:  PubMed          Journal:  J Med Cases        ISSN: 1923-4155


Introduction

Radiofrequency catheter ablation (RFA) is an effective treatment for recurrent symptomatic atrial fibrillation (AF) despite medical therapy. Complications include cardiac tamponade, pulmonary vein stenosis, gastrointestinal bleeding, new-onset arrhythmia, cardiac arrest, infections, thromboembolism (stroke), and rarely atrial-esophageal fistula (AEF) [1-4]. Symptoms of AEF vary from chest discomfort, cough, reflux symptoms, flu-like symptoms, to severe sepsis [5]. Usually, AEF occurs within 2 - 41 days following the procedure, and delay in management can lead to death [2, 5]. Our team presents a case of a 77-year-old male patient with a history of persistent AF who presented with chest discomfort, dysphagia, and stroke 50 days after pulmonary vein isolation. Imaging findings confirmed AEF.

Case Report

Investigations

A 77-year-old male patient with a history of persistent AF status post posterior left atrial isolation 50 days prior presented to the emergency department with bilateral lower extremity weakness ongoing for an hour. In addition, he reported a non-productive cough, chest discomfort, and dysphagia. His other past medical history included: prostate cancer status post prostatectomy (in remission), asthma, hypertension, hyperlipidemia, and obstructive sleep apnea. He never smoked tobacco in the past, and his family history was unremarkable. His daily oral medications were metoprolol, diltiazem, aspirin, pravastatin, telmisartan-hydrochlorothiazide, apixaban, and albuterol-ipratropium. On initial assessment, vitals were blood pressure of 193/110 mm Hg; respiratory rate of 28 breaths per minute; heart rate of 135 beats per minute; temperature of 102.3 °F; oxygen saturation of 91% on room air. Glasgow Coma Scale (GCS) score was 14 (E4, V4, M6). On physical examination, he was alert and oriented only to person and place. There was a decreased light tough sensation and 4/5 weakness in the bilateral lower extremities. Cranial nerves 2-12 were grossly intact. Cardiovascular examination was only significant for an irregular rhythm with tachycardia. Bilateral lungs sounds were audible on auscultation.

Diagnosis

Laboratory results revealed white blood cell count of 17.9 × 103/µL (normal value: 4.5 - 11.0 × 103/µL), and troponin I of 1.76 ng/mL (normal value: < 0.04 ng/mL). Other lab results showed glucose of 153 mg/dL (normal value: 70 - 99 mg/dL), blood urea nitrogen of 29 mg/dL (normal value: 7 - 18 mg/dL), creatinine of 1.34 mg/dL (normal value: 0.61 - 1.24 mg/dL), lactate of 2.4 mmol/L (normal value: 0.2 - 2.0 mmol/L), and creatinine kinase of 425 IU/L (normal value: 22 - 232 IU/L). An electrocardiogram showed irregularly irregular rhythm and no ST- or T-wave changes. Chest X-ray was unremarkable. Non-contrast CT scan of the head showed areas of low attenuation in the left parietal, temporal, and occipital region, with no acute intracranial hemorrhage. CT angiogram of the head and neck, CT perfusion neuro, and CT of the cervical spine without contrast were unremarkable. Magnetic resonance imaging of the brain with/without contrast revealed hyperintensity in both cerebral and cerebellar hemispheres, consistent with subacute infarcts suggestive of embolic disease (Fig. 1). Tissue plasminogen activator was contraindicated, as he was on apixaban. The patient was admitted for management of altered mental status and sepsis of an unknown origin. Due to associated chest discomfort and dysphagia, a CT scan of the chest with contrast obtained revealed a small focus of air between the posterior wall of the left atrium and the esophagus (Fig. 2). About 18 h later, he deteriorated with worsened hypoxic respiratory failure, altered mental status (GCS score of 6; E2, V2, M2), requiring intubation and mechanical ventilation.
Figure 1

Magnetic resonance imaging of the brain showing bilateral cerebral (a) and cerebellar infarcts (b).

Figure 2

Chest computed tomography scan with contrast showing air contrast (red arrows) within the cavity of the left atrium in the sagittal (a) and axial (b) views.

Magnetic resonance imaging of the brain showing bilateral cerebral (a) and cerebellar infarcts (b). Chest computed tomography scan with contrast showing air contrast (red arrows) within the cavity of the left atrium in the sagittal (a) and axial (b) views.

Treatment

Cardiothoracic surgery was consulted, and he was taken to the operation room for open-heart surgery due to concern for AEF. Cardiopulmonary bypass was initiated, and the aorta was cross-clamped to avoid embolization. Cardioplegia was achieved. Peri-operatively, there was an area of induration along the atrioventricular groove, and the left atrial appendage was completely stuck to the ventricular wall. A left atrial fistula measuring 0.5 cm was identified and closed. Also, a fibrinous material (3 × 4 cm) was identified and removed in the left inferior pulmonary vein. On post-operative day 1, he underwent an upper endoscopy, and a 1 cm esophageal defect was closed. Biopsy from fibrinous material was positive for polymicrobial organisms (lactobacillus, candida, and prevotella), while blood cultures grew Streptococcus anginosus.

Follow-up and outcomes

Despite treatment with aggressive intravenous antibiotics, the patient deteriorated with poor neurological function and ventilator dependency. A multidisciplinary team reached a consensus agreement for palliative measures.

Discussion

AF is considered to be the most significant cardiac arrhythmia in the USA clinically [4]. Although anti-arrhythmic drugs remain to be the cornerstone for AF management, RFA has become a satisfactory option for resistant cases of AF [4, 5]. RFA for the resistant type of AF is a commonly performed intervention in patients with paroxysmal AF who are categorized as the group of patients who are resistant to anti-arrhythmic drugs [4]. This procedure is usually performed during cardiac surgery as an additional measure or alone as a percutaneous procedure [4]. As per statistics, between 1990 and 2005 in the USA alone 133,000 cases of RFA had been carried out in resistant cases of AF [4]. Every year the number of RFA performed increases at an approximate rate of 15% [4]. Although there are several documented complications of RFA like pulmonary venous thrombosis, pulmonary venous stenosis, left atrial hematoma, etc., AEF is considered to be one of the most dreadful and fatal complications of RFA [6]. The first documented case of AEF as a complication of RFA was described in the year 2004 by Pappone et al [7]. Since then, there have been many case reports (more than 50) of AEF occurring as a complication of RFA [7-9]. As per the earlier studies, the incidence of AEF was very low following RFA, less than 0.04%. However, recent studies have documented a much higher rate at 0.2-0.4% [7-9]. It has a mortality rate of 40-80% [5]. Chest discomfort, cough, reflux symptoms, flu-like symptoms, and severe sepsis are some of the variable clinical presentations associated with this disease [4, 5]. A CT scan of the chest with contrast is regarded as the most reliable non-invasive test for AEF [5]. RFA has a higher success rate between 60% and 80% when compared to drug therapy for arrhythmia, but the depth of ablation is rather difficult to control and assess [10, 11]. Moreover, the anatomical proximity of the esophagus to the posterior wall of the left atrium (the two vital structures are separated by a thin layer of fat), contributes to the occurrence of AEF following RFA. It is further supported by the fact that around 30-47% of the patients who undergo RFA suffer from some degree of esophageal mucosal injury, if not a full degree of AEF [5, 11]. Several techniques are thought to decrease the risk of thermal injury, like using electroanatomic mapping systems, simultaneous use of intracardiac echocardiography, reduced power delivery, reduced tissue contact pressure with frequent change of probe positions, repeated measurement of the temperature of the esophagus, and fitting the catheter tip with temperature sensors [11, 12]. Given the fact that all these modifications have not been established conclusively to prevent AEF following RFA, early diagnosis and prompt management play a vital role in saving a patient’s life. Schuring et al published a case series with three cases in elderly males presenting with AEF following RFA. Despite aggressive measures, only one of the patients (case 2) survived, which the authors attributed to the fact that this patient was diagnosed and managed promptly [5]. Dagres et al presented a case series of five cases of AEF following RFA [13]. They noted that only three of the five patients survived and attributed early diagnosis and prompt surgical intervention as the reason behind the favorable outcome [13]. Furthermore, the bidirectional pressure differences between the esophagus and left atrium may lead to an increase in the size of the fistula [14]. If there is more intra-esophageal pressure compared to the intra-atrial pressure, movement of air or bacteria is directed towards the left atrium resulting in air embolism, bacteremia, septic embolism, or endocarditis as seen in our case [14]. Vice versa to this, there will be more blood leakage towards the esophagus resulting in gastrointestinal hemorrhage [14]. Therefore, manipulation (nasogastric, orogastric, and transesophageal echocardiography) of the esophagus will result in the widening of this defect and should be contraindicated if AEF is suspected, until after surgery. Our patient presented to the emergency department with bilateral lower extremity weakness, chest discomfort, non-productive cough, and dysphagia 50 days after left pulmonary vein isolation. CT of the chest confirmed AEF, while magnetic resonance imaging of the brain with/without contrast revealed hyperintensity in both cerebral and cerebellar hemispheres, consistent with subacute infarcts suggestive of embolic disease. Despite undergoing aggressive management for his newly diagnosed infective endocarditis and septic emboli, he passed away. To our knowledge, this case represents one of the few cases documenting life-threatening infective endocarditis with septic emboli as a complication of AEF from RFA. Therefore, clinicians should have a high index of suspicion due to associated grave prognosis.

Learning points

AEF is a rare complication of RFA. Chest CT scan with contrast has been reported to be the gold standard non-invasive test in diagnosing this iatrogenic defect. Neurologic/cardiac complications of AEF following RFA are rare sequela, and without prompt intervention in most of the cases, the outcome is fatal. Hence increased awareness with rapid diagnosis and immediate surgical intervention are of utmost importance to improve outcomes.
  14 in total

1.  Esophageal injury following left atrial ablation.

Authors:  Bashar J Qumseya; Fred Kusumoto; Herbert Wolfsen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

2.  Atrial-esophageal fistula after atrial radiofrequency catheter ablation.

Authors:  Marc O Siegel; David M Parenti; Gary L Simon
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

3.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

4.  Trends in catheter ablation for atrial fibrillation in the United States.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  J Hosp Med       Date:  2009-09       Impact factor: 2.960

Review 5.  Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy.

Authors:  Fang Yi; Wenbo Hou; Chao Zhou; Yuxia Yin; Shoutao Lu; Cuihai Duan; MingKun Cao; Maoquan Li; Egon Steen Toft; Haijun Zhang
Journal:  J Cardiovasc Pharmacol       Date:  2019-04       Impact factor: 3.105

6.  Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.

Authors:  Carlo Pappone; Hakan Oral; Vincenzo Santinelli; Gabriele Vicedomini; Christopher C Lang; Francesco Manguso; Lucia Torracca; Stefano Benussi; Ottavio Alfieri; Robert Hong; William Lau; Kirk Hirata; Neil Shikuma; Burr Hall; Fred Morady
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

Review 7.  Left Atrial to Esophageal Fistula: A Case Report and Literature Review.

Authors:  Muhammad Yasir Khan; Waqas Javed Siddiqui; Praneet S Iyer; Ahmed Dirweesh; Nigahus Karabulut
Journal:  Am J Case Rep       Date:  2016-11-02

8.  Successful management of atrio-esophageal fistula after cardiac radiofrequency catheter ablation.

Authors:  Hun Bo Shim; Chilsung Kim; Hong-Kwan Kim; Kiick Sung
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-04-09

Review 9.  Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports.

Authors:  Patricia Chavez; Franz H Messerli; Abel Casso Dominguez; Emad F Aziz; Tina Sichrovsky; Daniel Garcia; Connor D Barrett; Stephan Danik
Journal:  Open Heart       Date:  2015-09-10

Review 10.  Atrio-Esophageal Fistula: A Case Series and Literature Review.

Authors:  Craig A Schuring; Luke J Mountjoy; Ashley B Priaulx; Robert J Schneider; Hayden L Smith; Geoffrey C Wall; Dipen Kadaria; Amik Sodhi
Journal:  Am J Case Rep       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.